Trials / Completed
CompletedNCT01452425
In Vivo Optical Spectroscopy Monitoring in a New Model of Muscular Compartment Syndrome
In Vivo Optical Spectroscopy Monitoring in a New Model of Muscular Compartment Syndrome.
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 10 (actual)
- Sponsor
- Université Catholique de Louvain · Academic / Other
- Sex
- Male
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Accepted
Summary
Muscular compartment syndrome (MCS) is consecutive to an increase in intramuscular compartment pressures, and is a rare but serious postoperative complication. The INVOS (In Vivo Optical Spectroscopy) monitors tissular oxygenation continuously and non-invasively. The objective is to develop a model mimicking the physiopathology of MCS to assess the interest of the INVOS in this case.
Detailed description
After inflation of a tourniquet (pressure equal to the mean arterial pressure, we will obtain a model of slight venous congestion and arterial hypoperfusion. A comparison will be made between INVOS monitoring, sensory deficits, pain, electromyography and invasive pressure.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Tourniquet | Inflation of a tourniquet (pressure equal to the mean arterial pressure) obtaining a model of slight venous congestion and arterial hypoperfusion |
| DEVICE | INVOS assessment | Near Infraread spectroscopy, non invasive |
| DEVICE | EMG assessment | Electromyography, non invasive |
Timeline
- Start date
- 2011-10-01
- Primary completion
- 2011-12-01
- Completion
- 2011-12-01
- First posted
- 2011-10-14
- Last updated
- 2014-12-22
- Results posted
- 2014-12-22
Locations
1 site across 1 country: Belgium
Source: ClinicalTrials.gov record NCT01452425. Inclusion in this directory is not an endorsement.